2 news items
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
CNTB
16 Apr 24
in December 2023 on the Phase 2 trial of icanbelimod showing that patients with UC would likely derive greater clinical benefit with higher doses than
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
CNTB
12 Feb 24
any benefit, improvement, differentiation, trend or profile or any product approval or be effective. The inclusion of forward-looking statements
- Prev
- 1
- Next